ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Edwards Lifesciences Corporation (EW), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live EW chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
6.07B
YoY+11.5%
5.44B
YoY+8.6%
5.01B
YoY+12.2%
4.46B
YoY-14.7%
5.23B
YoY+19.3%
4.73B
YoY+9.5%
4.32B
YoY+7.2%
4.03B
YoY+7.8%
3.74B
YoY-6.1%
3.98B
YoY+20.5%
Research & development
1.08B
YoY+2.5%
1.05B
YoY+9.4%
963M
YoY+14.1%
844M
YoY-6.6%
903M
YoY+18.7%
Selling, general & administrative
2.09B
YoY+16.5%
1.79B
YoY+13.1%
1.58B
YoY+16.6%
1.36B
YoY-9.1%
1.49B
YoY+21.6%
Restructuring
13.1M
YoY-60.2%
32.9M
Amortization of intangibles
8.40M
YoY+50.0%
5.60M
YoY+154.5%
2.20M
YoY-4.3%
2.30M
YoY-70.1%
7.70M
YoY+42.6%
Operating income
1.26B
YoY-8.3%
1.38B
YoY+5.3%
1.31B
YoY-12.6%
1.50B
YoY-11.4%
1.69B
YoY+88.3%
Interest expense
20.4M
YoY+3.0%
19.8M
YoY+12.5%
17.6M
YoY-8.3%
19.2M
YoY+4.3%
18.4M
YoY+16.5%
Interest & investment income
169M
YoY+40.3%
120M
YoY+79.0%
67.2M
YoY+89.3%
35.5M
YoY+104.0%
17.4M
YoY-25.6%
Net interest income
-20.4M
YoY-3.0%
-19.8M
YoY-12.5%
-17.6M
Other non-operating income
7.20M
YoY-89.6%
68.9M
YoY+395.7%
13.9M
YoY+189.6%
4.80M
YoY-62.2%
12.7M
YoY+10.4%
Pre-tax income
1.27B
YoY-17.8%
1.55B
YoY+12.8%
1.37B
YoY-9.7%
1.52B
YoY-10.7%
1.70B
YoY+85.7%
Income tax
217M
YoY+42.6%
152M
YoY-0.2%
152M
YoY-22.0%
196M
YoY-1.7%
199M
YoY+113.2%
1.07B
YoY-74.3%
4.17B
YoY+197.7%
1.40B
YoY-7.9%
1.52B
YoY+1.3%
1.50B
$1.83
YoY-73.7%
$6.97
YoY+203.0%
$2.30
YoY-5.7%
$2.44
YoY+2.5%
$2.38
YoY+83.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.74B
YoY+7.2%
6.29B
YoY+55.7%
4.04B
YoY+30.4%
3.10B
YoY-2.7%
3.18B
YoY+2.9%
13.7B
YoY+4.9%
13.1B
YoY+39.4%
9.36B
YoY+12.9%
8.29B
YoY-2.5%
8.50B
YoY+17.5%
1.81B
YoY+20.5%
1.51B
YoY+25.9%
1.20B
YoY+16.9%
1.02B
YoY-1.0%
1.03B
YoY+15.5%
3.36B
YoY+12.3%
2.99B
YoY+13.2%
2.64B
YoY+6.4%
2.49B
YoY-6.8%
2.67B
YoY+0.1%
10.3B
YoY+3.4%
10.00B
YoY+50.4%
6.65B
YoY+14.5%
5.81B
YoY-0.5%
5.84B
YoY+27.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.60B
YoY+194.2%
542M
YoY-39.5%
896M
YoY-26.5%
1.22B
YoY-29.7%
1.73B
YoY+64.3%
-713M
YoY-130.8%
2.31B
YoY+1230.8%
174M
YoY-31.1%
252M
YoY+114.6%
-1.72B
YoY-224.3%
-957M
YoY+2.7%
-983M
YoY-38.3%
-711M
YoY+55.1%
-1.58B
YoY-344.7%
-356M
YoY+26.8%
FX effect on cash
-44.8M
YoY-216.1%
38.6M
YoY+129.8%
16.8M
YoY-12.5%
19.2M
YoY+38.1%
13.9M
YoY+167.8%
Net change in cash
-119M
YoY-106.2%
1.91B
YoY+409.0%
375M
YoY+496.0%
-94.8M
YoY+71.5%
-333M
YoY-2206.3%
Interest paid
20.2M
YoY+3.1%
19.6M
YoY-1.5%
19.9M
YoY+3.1%
19.3M
YoY-4.5%
20.2M
YoY+1.5%
Income taxes paid
490M
YoY-59.0%
1.20B
YoY+154.4%
470M
YoY-6.7%
504M
YoY+176.2%
183M
YoY-7.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
49.5B
YoY+13.3%
43.7B
YoY-5.6%
46.2B
YoY+0.3%
46.1B
YoY-43.0%
80.9B
YoY+42.3%
P/E
46.1×
YoY+340.6%
10.5×
YoY-67.7%
32.4×
P/S
8.2×
YoY+1.6%
8.0×
YoY-27.7%
11.1×
YoY+28.8%
8.6×
YoY-44.2%
15.5×
YoY+19.2%
P/B
4.8×
YoY+9.6%
4.4×
YoY-37.3%
7.0×
YoY-6.4%
7.4×
YoY-46.3%
13.9×
YoY+11.5%
P/FCF
37.1×
YoY-75.4%
150.6×
YoY+162.7%
57.3×
YoY+29.4%
44.3×
YoY-22.9%
57.5×
YoY-34.5%
Earnings yield
2.2%
YoY-77.3%
9.6%
YoY+209.7%
3.1%
FCF yield
2.7%
YoY+306.4%
0.7%
YoY-61.9%
1.7%
YoY-22.7%
2.3%
YoY+29.8%
1.7%
YoY+52.7%
Source filing10-K10-K10-K10-K10-K

About this data

Source: EW's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EW filings on SEC EDGAR → Not investment advice.